Your browser doesn't support javascript.
loading
Combined Inhibition of Smoothened and the DNA Damage Checkpoint WEE1 Exerts Antitumor Activity in Cholangiocarcinoma.
Anichini, Giulia; Raggi, Chiara; Pastore, Mirella; Carrassa, Laura; Maresca, Luisa; Crivaro, Enrica; Lottini, Tiziano; Duwe, Lea; Andersen, Jesper B; Tofani, Lorenzo; Di Tommaso, Luca; Banales, Jesus M; Arcangeli, Annarosa; Marra, Fabio; Stecca, Barbara.
  • Anichini G; Core Research Laboratory - Institute for Cancer Research and Prevention (ISPRO), Florence, Italy.
  • Raggi C; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
  • Pastore M; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
  • Carrassa L; Core Research Laboratory - Institute for Cancer Research and Prevention (ISPRO), Florence, Italy.
  • Maresca L; Core Research Laboratory - Institute for Cancer Research and Prevention (ISPRO), Florence, Italy.
  • Crivaro E; Core Research Laboratory - Institute for Cancer Research and Prevention (ISPRO), Florence, Italy.
  • Lottini T; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
  • Duwe L; Biotech Research and Innovation Centre (BRIC), Dept. of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Andersen JB; Biotech Research and Innovation Centre (BRIC), Dept. of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Tofani L; Department of Statistics, University of Florence, Florence, Italy.
  • Di Tommaso L; Pathology Department, Humanitas Clinical and Research Center - IRCCS, Rozzano, Milan, Italy.
  • Banales JM; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.
  • Arcangeli A; Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute - Donostia University Hospital, University of the Basque Country (UPV/EHU), San Sebastian, Spain.
  • Marra F; National Institute for the Study of Liver and Gastrointestinal Diseases (CIBERehd, "Instituto de Salud Carlos III"), Madrid, Spain.
  • Stecca B; Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisbon, Portugal.
Mol Cancer Ther ; 22(3): 343-356, 2023 03 02.
Article en En | MEDLINE | ID: mdl-36807728
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Colangiocarcinoma / Proteínas Hedgehog Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Colangiocarcinoma / Proteínas Hedgehog Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article